| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/31/2007 | WO2007061750A2 Adipose tissue derived stromal cells for the treatment of neurological disorders |
| 05/31/2007 | WO2007061627A2 Direct dna delivery to bone cells |
| 05/31/2007 | WO2007061053A1 Hybrid promoter composed of muscle-tropic promoter and sv40 virus promoter and vector carrying the hybrid promoter |
| 05/31/2007 | WO2007060899A1 Application of actin-binding protein to disease associated with cell motility |
| 05/31/2007 | WO2007059612A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | WO2007059605A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 05/31/2007 | WO2007037560A9 Therapeutic or diagnostic application of sgk2 gene |
| 05/31/2007 | WO2007037555A9 Therapeutic or diagnostic application of dusp15 gene |
| 05/31/2007 | WO2007037550A9 Therapeutic or diagnostic application of tsta3 gene |
| 05/31/2007 | WO2007037538A9 Therapeutic or diagnostic application of spo11 gene |
| 05/31/2007 | WO2007037533A9 Therapeutic or diagnostic application of ppp1r3d gene |
| 05/31/2007 | WO2007037532A9 Therapeutic or diagnostic application of srms gene |
| 05/31/2007 | WO2007037514A9 Novel application of heparin-binding epidermal growth factor-like growth factor for medical purposes |
| 05/31/2007 | WO2007031590A9 Method for the in vitro detection of a predisposition to the development of alterations in ovarian function |
| 05/31/2007 | WO2007014469A8 Hepatitis c antivirals |
| 05/31/2007 | WO2006116862A9 Method for inhibiting er stress-induced apoptosis |
| 05/31/2007 | WO2006052911A3 Laforin expression in diagnosis and treatment of cancer and other diseases |
| 05/31/2007 | WO2006042418A9 Antiviral oligonucleotides |
| 05/31/2007 | WO2006023544A3 Therapeutic uses of inhibitors of rtp801 |
| 05/31/2007 | WO2005094338A3 Treatment of type 1 diabetes with inhibitors of macrophage migration inhibitory factor |
| 05/31/2007 | WO2005032483A3 Polysaccharides for pulmonary delivery of active agents |
| 05/31/2007 | US20070124825 Use of hepcidin as a regulator of iron homeostasis |
| 05/31/2007 | US20070123487 Methods and Compositions for Treating Prostate Cancer Using DNA Vaccines |
| 05/31/2007 | US20070123486 Composition for coordinated VEGF and PDGF expression, and methods of use |
| 05/31/2007 | US20070123485 Introduction of double-stranded short interference RNA into the cells and reducing the expression of the corresponding messenger RNA in the cells; for inhibiting expression of a target gene in a cell |
| 05/31/2007 | US20070123484 Double strand compositions comprising differentially modified strands for use in gene modulation |
| 05/31/2007 | US20070123483 Method and composition for treating obesity by targeting cathespin |
| 05/31/2007 | US20070123482 Chemically modified oligonucleotides for use in modulating micro RNA and uses thereof |
| 05/31/2007 | US20070123481 Antisense IAP oligonucleotides and uses thereof |
| 05/31/2007 | US20070123480 Oligonucleotides targeting prion diseases |
| 05/31/2007 | US20070123479 single chain antibody construct comprising binding domains specific for human CD3 and human CD19; anticarcinogenic biodrug for treating non-Hodgkin lymphoma |
| 05/31/2007 | US20070123464 Methods and reagents for treating inflammation and fibrosis |
| 05/31/2007 | US20070123459 IL-17 like molecules and uses thereof |
| 05/31/2007 | US20070123452 Method of selecting novel immunosuppressant |
| 05/31/2007 | US20070122821 Antisense composition and method for treating muscle atrophy |
| 05/31/2007 | US20070122427 Delivery of trefoil peptides |
| 05/31/2007 | US20070122414 Surface marker-directed cancer therapeutics |
| 05/31/2007 | US20070122412 Eg-vegf nucleic acids and polypeptides and methods of use |
| 05/31/2007 | US20070122401 Methods and compositions for modulating telomerase reverse transcriptase (tert) expression |
| 05/31/2007 | US20070122396 Morphogenic proteins and stimulatory factors in gene therapy |
| 05/31/2007 | US20070122395 Genetic and pharmacological regulation of antidepressant-sensitive biogenic amine transporters through PKG/p38 map kinase |
| 05/31/2007 | US20070122394 administering a VEGFR modulating agent that comprises placental growth factor; a growth factor that binds and activates Flt-1 such as PIGF or VEGF-B, an anti-Flt-1 agonistic antibody or a small molecule agonist |
| 05/31/2007 | US20070122393 Immunophenotype and immunogenicity of human adipose derived cells |
| 05/31/2007 | US20070122392 Propagation of undifferentiated embryonic stem cells in hyaluronic acid hydrogel |
| 05/31/2007 | US20070122391 Compositions and methods for non-targeted activation of endogenous genes |
| 05/31/2007 | US20070122385 Replication competent viruses capable of silencing virus inhibitory factor expression |
| 05/31/2007 | US20070122381 Method for regulating neuron development and maintenance |
| 05/31/2007 | US20070122379 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms |
| 05/31/2007 | US20070122378 Methods and compositions for the treatment of persistent infections |
| 05/31/2007 | CA2628530A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/31/2007 | CA2628313A1 Composition and method for efficient delivery of nucleic acids to cells using chitosan |
| 05/30/2007 | EP1790730A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790729A2 Streptococcus pneumoniae proteins and nucleic acid molecules |
| 05/30/2007 | EP1790728A2 Imaging, diagnosis and treatment of disease |
| 05/30/2007 | EP1790727A2 Proteins and nucleic acids encoding same |
| 05/30/2007 | EP1790726A2 Modified and stabilized GDF propeptides and uses thereof |
| 05/30/2007 | EP1790658A2 Anti-viral vectors |
| 05/30/2007 | EP1789095A2 Compositions and methods for protein production |
| 05/30/2007 | EP1789094A1 Bacterial delivery system |
| 05/30/2007 | EP1789082A1 Cytokine-expressing cellular vaccines for treatment of prostate cancer |
| 05/30/2007 | EP1789080A2 Cd25 dna vaccines for treating and preventing t-cell mediated diseases |
| 05/30/2007 | EP1789071A2 Pik4ca as modifier of the rac pathway and methods of use |
| 05/30/2007 | EP1578921A4 Mammalian migration inducting gene and methods for detection and inhibition of migrating tumor cells |
| 05/30/2007 | EP1373487B1 Regulation of human protein kinase-like protein |
| 05/30/2007 | EP1171165B1 Intramyocardial injection of autologous bone marrow |
| 05/30/2007 | EP0975754B1 Osteoprotegerin binding proteins and receptors |
| 05/30/2007 | CN1972958A Method of using adenoviral vectors to induce an immune response |
| 05/30/2007 | CN1972709A Treatment method of non alcoholic steatotic hepatitis (NASH) |
| 05/30/2007 | CN1972593A Use of interfering RNA in the production of transgenic animals |
| 05/30/2007 | CN1970772A Sequence, plasmid, and engineering bacteria for use in disease control of aquatic animal and application thereof |
| 05/30/2007 | CN1970591A Biodegradable crosslinked polyethylenimine and its uses |
| 05/30/2007 | CN1970074A Application of beta-protein inhibitor in preparation of medicament for treating genetic correlated disease |
| 05/30/2007 | CN1318596C Vectors based on recombinant defective viral gene group, and their use in formulation of vaccines |
| 05/30/2007 | CN1318592C O type foot and mouth disease virus DNA vaccine and its preparing method |
| 05/30/2007 | CN1318590C Human protooncogene KG-20 and protein encoded therein |
| 05/30/2007 | CN1318588C Osteoprotegerine |
| 05/30/2007 | CN1318586C Method for the in vitro synthesis of short double stranded RNAs |
| 05/30/2007 | CN1318576C Targeted cytolysis of HIV-infected cells by chimerical CD4 receptor bearing cells |
| 05/30/2007 | CN1318575C Protein conformational disease cell model and its use |
| 05/30/2007 | CN1318447C Tumor antigen peptides originating in cyclophilin B |
| 05/30/2007 | CN1318091C Use of biologically active HIV-1 Tat, fragments or derivatives thereof for preventing or therapeutic vaccination and/or treating other diseases |
| 05/30/2007 | CN1318023C Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 05/29/2007 | US7223852 Nucleic acids encoding TRAIN-R: a cysteine rich member of the TNF-receptor family |
| 05/29/2007 | US7223743 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/29/2007 | US7223741 nucleic acids containing unmethylated cytosine-guanine (CpG) dinucleotides activate lymphocytes in a subject and redirect a subject's immune response from a Th2 to a Th1 |
| 05/29/2007 | US7223740 isolated host cell; treatment of arterial diseases, comprising intramuscularly administering a vector |
| 05/29/2007 | US7223739 Adjuvanted genetic vaccines |
| 05/29/2007 | US7223729 Suppressing an immune response, CD200, a molecule with previously unknown function belonging to the Ig superfamily, is an immune suppressant; preventing graft rejection, fetal loss, autoimmune diseases, allergies |
| 05/29/2007 | US7223724 Administering a polypeptide attached to a water soluble polymer; treating age-related macular degeneration, diabetic retinopathy, peripheral vitreoretinopathies, photic retinopathies, surgery-induced retinopathies, viral retinopathies, ischemlc retinopathies, retinal detachment and traumatic retinopathy |
| 05/29/2007 | US7223600 cell is contacted with a photosentistising agent, cell is irradiated with light to activate photosentisitising agent, the cell is contacted with the molecule to be introduced, particularly for use in cancer treatment, gene therapy and vaccination |
| 05/29/2007 | US7223594 Immunogens; replication-defective; antibodies; host cells; kits |
| 05/29/2007 | US7223593 Anticancer agents; gene coding immunomoderator cytokine protein |
| 05/29/2007 | US7223585 Viral purification methods |
| 05/29/2007 | US7223563 Nucleic acids; diagnosing and treating hypophosphatemic disorders; diagnosing tumor induced osteomalacia |
| 05/29/2007 | US7223542 Diagnosing cancer via determining concentration of marker polypeptides; genetic vaccines; antiproliferative/antitumor agents |
| 05/29/2007 | US7223407 Immunogens; water-in-oil emulsions; oil-in-water emulsions; vaccines; freeze drying |
| 05/29/2007 | US7223406 Administering one or more factors selecting from vascular endothelial growth factor, brain-derived neurotrophic factor, fibroblast growth factor, neurotrophins or angiopoietin-1; promoting the growth of new nerve fibers; tissue engineering |
| 05/29/2007 | US7223398 Population of conjugate molecules of an allergen and a polynucleotide comprising an immunostimulatory sequence; polynucleotide conjugated, or attached, to antigens |
| 05/29/2007 | US7223395 Blocking leukocyte emigration and inflammation by interfering with CD99/HEC2 |
| 05/29/2007 | US7223389 Compositions and methods for treatment of cancer |